Identification of a CCR5-expressing T cell subset that is resistant to R5-tropic HIV infection

被引:48
作者
Oswald-Richter, Kyra
Grill, Stacy M.
Leelawong, Mindy
Tseng, Michelle
Kalams, Spyros A.
Hulgan, Todd
Haas, David W.
Unutmaz, Derya [1 ]
机构
[1] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN USA
[2] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN USA
[3] Vanderbilt Univ, Sch Med, Div Infect Dis, Nashville, TN USA
关键词
D O I
10.1371/journal.ppat.0030058
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Infection with HIV-1 perturbs homeostasis of human T cell subsets, leading to accelerated immunologic deterioration. While studying changes in CD4(+) memory and naive T cells during HIV-1 infection, we found that a subset of CD4(+) effector memory T cells that are CCR7(-) CD45RO(-) CD45RA(-) (referred to as T-EMRA cells), was significantly increased in some HIV-infected individuals. This T cell subset displayed a differentiated phenotype and skewed Th1-type cytokine production. Despite expressing high levels of CCR5, T-EMRA cells were strikingly resistant to infection with CCR5 (R5)-tropic HIV-1, but remained highly susceptible to CXCR4 (X4)-tropic HIV-1. The resistance of T-EMRA cells to R5-tropic viruses was determined to be post-entry of the virus and prior to early viral reverse transcription, suggesting a block at the uncoating stage. Remarkably, in a subset of the HIV-infected individuals, the relatively high proportion of T-EMRA cells within effector T cells strongly correlated with higher CD4(+) T cell numbers. These data provide compelling evidence for selection of an HIV-1-resistant CD4(+) T cell population during the course of HIV-1 infection. Determining the host factors within T-EMRA cells that restrict R5-tropic viruses and endow HIV-1-specific CD4(+) T cells with this ability may result in novel therapeutic strategies against HIV-1 infection.
引用
收藏
页码:553 / 565
页数:13
相关论文
共 42 条
[1]  
Beverley P C, 1992, Semin Immunol, V4, P35
[2]   CCR5 and HIV infection [J].
Blanpain, C ;
Libert, F ;
Vassart, G ;
Parmentier, M .
RECEPTORS & CHANNELS, 2002, 8 (01) :19-31
[3]   T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: Implications for HIV pathogenesis [J].
Brenchley, JM ;
Hill, BJ ;
Ambrozak, DR ;
Price, DA ;
Guenaga, FJ ;
Casazza, JP ;
Kuruppu, J ;
Yazdani, J ;
Migueles, SA ;
Connors, M ;
Roederer, M ;
Douek, DC ;
Koup, RA .
JOURNAL OF VIROLOGY, 2004, 78 (03) :1160-1168
[4]   CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract [J].
Brenchley, JM ;
Schacker, TW ;
Ruff, LE ;
Price, DA ;
Taylor, JH ;
Beilman, GJ ;
Nguyen, PL ;
Khoruts, A ;
Larson, M ;
Haase, AT ;
Douek, DC .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (06) :749-759
[5]   A quantitative assay for HIV DNA integration in vivo [J].
Butler, SL ;
Hansen, MST ;
Bushman, FD .
NATURE MEDICINE, 2001, 7 (05) :631-634
[6]   Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire [J].
Campbell, JJ ;
Qin, SX ;
Unutmaz, D ;
Soler, D ;
Murphy, KE ;
Hodge, MR ;
Wu, LJ ;
Butcher, EC .
JOURNAL OF IMMUNOLOGY, 2001, 166 (11) :6477-6482
[7]   A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes [J].
Cavrois, M ;
de Noronha, C ;
Greene, WC .
NATURE BIOTECHNOLOGY, 2002, 20 (11) :1151-1154
[8]  
CAYOTA A, 1993, CLIN EXP IMMUNOL, V91, P241
[9]   Quantification of latent tissue reservoirs and total body viral load in HIV-1 Infection [J].
Chun, TW ;
Carruth, L ;
Finzi, D ;
Shen, XF ;
DiGiuseppe, JA ;
Taylor, H ;
Hermankova, M ;
Chadwick, K ;
Margolick, J ;
Quinn, TC ;
Kuo, YH ;
Brookmeyer, R ;
Zeiger, MA ;
BarditchCrovo, P ;
Siliciano, RF .
NATURE, 1997, 387 (6629) :183-188
[10]   Change in coreceptor use correlates with disease progression in HIV-1-infected individuals [J].
Connor, RI ;
Sheridan, KE ;
Ceradini, D ;
Choe, S ;
Landau, NR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (04) :621-628